mRNA Synthesis and Manufacturing Services Market Size, Share and Growth Analysis 2025 to 2034
Segmentation of mRNA Synthesis and Manufacturing Services Market-
mRNA Synthesis and Manufacturing Services Market By Products-
- API
- Drug Products
mRNA Synthesis and Manufacturing Services Market By Type of Industry-
- Therapeutics and Vaccine Developers
- CDMO Organizations
- Custom Synthesis/Other Service Providers
mRNA Synthesis and Manufacturing Services Market By Therapeutic Area-
- Infectious Diseases
- Oncological Disorders
- Other Diseases
mRNA Synthesis and Manufacturing Services Market By Scale of Operation-
- Research / Preclinical
- Clinical
- Commercial
mRNA Synthesis and Manufacturing Services Market By Application-
- mRNA-based Vaccines
- mRNA-based Therapeutics
mRNA Synthesis and Manufacturing Services Market By Region-
North America-
- The US
- Canada
Europe-
- Germany
- The UK
- France
- Italy
- Spain
- Rest of Europe
Asia-Pacific-
- China
- Japan
- India
- South Korea
- South East Asia
- Rest of Asia Pacific
Latin America-
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Middle East & Africa-
- GCC Countries
- South Africa
- Rest of the Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global mRNA Synthesis and Manufacturing Services Market Snapshot
Chapter 4. Global mRNA Synthesis and Manufacturing Services Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
4.9. Clinical Trial/Pipeline Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Type of Industry & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type of Industry:
5.2.1. API
5.2.2. Drug Products
Chapter 5. Market Segmentation 2: By Type of Industry Estimates & Trend Analysis
5.1. By Type of Industry & Market Share, 2024 & 2034
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Type of Industry:
5.2.1. Therapeutics and Vaccine Developers
5.2.2. CDMO Organizations
5.2.3. Custom Synthesis/cGMP Service Providers
Chapter 6. Market Segmentation 3: By Therapeutic Area Estimates & Trend Analysis
6.1. By Therapeutic Area & Market Share, 2024 & 2034
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Applications:
6.2.1. Infectious Disease
6.2.2. Oncological Disorders
6.2.3. Others
Chapter 7. Market Segmentation 4: By Scale of Operation Estimates & Trend Analysis
7.1. By Scale of Operation & Market Share, 2024 & 2034
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Scale of Operation:
7.2.1. Research / Preclinical
7.2.2. Clinical
7.2.3. Commercial
Chapter 8. Market Segmentation 4: By Application Estimates & Trend Analysis
8.1. By Application & Market Share, 2024 & 2034
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2021 to 2034 for the following By Application:
8.2.1. mRNA-based Vaccines
8.2.2. mRNA-based Therapeutics
Chapter 9. mRNA Synthesis and Manufacturing Services Market Segmentation 5: Regional Estimates & Trend Analysis
9.1. North America
9.1.1. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.1.2. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034
9.1.3. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034
9.1.4. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
9.1.5. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034
9.1.6. North America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.2. Europe
9.2.1. EuropemRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.2.2. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034
9.2.3. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034
9.2.4. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
9.2.5. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034
9.2.6. Europe mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.3. Asia Pacific
9.3.1. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.3.2. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034
9.3.3. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034
9.3.4. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
9.3.5. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034
9.3.6. Asia Pacific mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.4. Latin America
9.4.1. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.4.2. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034
9.4.3. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034
9.4.4. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
9.4.5. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034
9.4.6. Latin America mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
9.5. Middle East & Africa
9.5.1. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Products, 2021-2034
9.5.2. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Applications, 2021-2034
9.5.3. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by Scale of Operation, 2021-2034
9.5.4. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Therapeutic Area, 2021-2034
9.5.5. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts By Type of Industry, 2021-2034
9.5.6. Middle East & Africa mRNA Synthesis and Manufacturing Services Market revenue (US$ Million) estimates and forecasts by country, 2021-2034
Chapter 10. Competitive Landscape
10.1. Major Mergers and Acquisitions/Strategic Alliances
10.2. Company Profiles
10.2.1. Eurogentec
10.2.2. Aldevron
10.2.3. eTheRNA (Etherna Immunotherapies)
10.2.4. bioSYNTHESIS
10.2.5. TriLink BioTechnologies
10.2.6. Biomay
102.7. Jena Biosciences
10.2.8. APExBIO
10.2.9. CELLSCRIPT
10.2.10. Thermo Fisher Scientific
10.2.11. New England Biolabs
10.2.12. Celonic AG
10.2.13. Corden Pharma GmbH
10.2.14. Lonza Group AG
10.2.15. Rentschler Biopharma
10.2.16. Laboratorios Farmacéuticos Rovi, S.A.
10.2.17. Samsung Biologics
10.2.18. CureVac
10.2.19. Moderna
10.2.20. BioNTech (Pfizer)
10.2.21. Translate Bio
10.2.22. Ethris (AstraZeneca)
10.2.23. Kernal Biologics
10.2.24. Silence Therapeutics
10.2.25. Tiba Biotechnology
10.2.26. In-Cell-Art
10.2.27. Anima Biotech
10.2.28. H3 Biomedicine Inc.
10.2.29. Arcturus Therapeutics
10.2.30. eFFECTOR Therapeutics, Inc.
10.2.31. Ionis Pharmaceuticals, Inc.
10.2.32. Stemirna Therapeutics Co., Ltd.
10.2.33. Skyhawk Therapeutics, Inc.
10.2.34. RNAimmune (Sirnaomics)
10.2.35. Ziphius Therapeutics NV
10.2.36. miRagen Therapeutics, Inc.
10.2.37. Strand Therapeutics Inc.
10.2.38. Other Prominent Players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
CureVac, Moderna, BioNTech (Pfizer), Translate Bio, Ethris (AstraZeneca), Silence Therapeutics, Tiba Biotechnology, In-Cell-Art, Anima Biotech, H3 Bio
mRNA Synthesis and Manufacturing Services Market is expected to grow at a 7.7% CAGR during the forecast period for 2025 to 2034
mRNA Synthesis and Manufacturing Services Market Size is valued at USD 958.5 Mn in 2024 and is predicted to reach USD 2,294.9 Mn by year 2034
By Type of Industry, Application, Scale of operations, Product and Therapeutic Area are the key segments of the Iprodione Market.
North American region is leading the mRNA Synthesis and Manufacturing Services Market.